Registration
SIMS STRATEGIES, LLC for BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
Firm
Income
—
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Issues related to the Biologics Price Competition and Innovation Act of 2009. Issues related to FDA user fee legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD PRETTYMAN New | Legislative Correspondent and Constituent Services Representative, Sen. Tom Carper (D-DE) |
| MICHAELA SIMS New | Legislative Counsel, Sen. Ben Nelson (D-NE); Legislative Director and Counsel, Sen. Bob Kerrey (D-NE) |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| BOEHRINGER INGELHEIM INTERNATIONAL GMBH | Germany | Germany | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.